Form 4: Astronics CEO Exercises Options, Updates Holdings
Insider Transaction Report
Astronics Corp. CEO Peter J. Gundermann reported exercising stock options and subsequent tax-related share withholdings, updating his beneficial ownership.
Summary
- Peter J. Gundermann, President/CEO and Director of Astronics Corp (ATRO), reported transactions on November 20, 2025.
- The filing is an original Form 4, correcting an inadvertent filing on November 24, 2025, which was incorrectly submitted as an amendment.
- Gundermann acquired 13,700 shares of $.01 PV Common Stock and 4,418 shares of $.01 PV Class B Stock upon the exercise of stock options, both at an exercise price of $27.72 per share.
- Following the option exercise, 11,707 shares of $.01 PV Common Stock were disposed of (withheld by Astronics Corp.) to satisfy applicable withholding taxes at a price of $49.35 per share.
- After these transactions, Gundermann beneficially owns 83,906.608 shares of $.01 PV Common Stock and 747,911 shares of $.01 PV Class B Stock directly.
- The filing also details various outstanding stock options with exercise prices ranging from $9.74 to $35.61, and expiration dates extending to December 5, 2034.
- Outstanding Restricted Stock Units (RSUs) include a target of 9,206 units vesting on February 23, 2026, 26,450 units vesting on February 23, 2027, and 25,250 units vesting on February 27, 2028.
- Vesting of these RSUs is performance-based, tied to Astronics Corp.'s average annual adjusted EBITDA for specific periods, with actual vesting percentages ranging from 50% to 150% of the target number.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of an insider transaction (option exercise and tax withholding) and corrects a minor administrative filing error. It does not contain information that significantly alters the company's financial outlook or strategic direction, thus maintaining a neutral sentiment.
Positives
- The CEO exercised stock options at $27.72 per share, while shares were withheld for tax at a higher price of $49.35 per share, indicating a significant unrealized gain on the exercised options and suggesting the stock price has appreciated since the options were granted.
- The exercise of options demonstrates management's confidence in the company's value, as it converts potential gains into actual shares.
Negatives
- 11,707 shares of common stock were withheld by Astronics Corp. to cover tax obligations, reducing the direct beneficial ownership of the reporting person.
Risks
- The vesting of a significant portion of the CEO's Restricted Stock Units (RSUs) is contingent upon Astronics Corp.'s average annual adjusted EBITDA performance for periods ending December 31, 2025, December 31, 2026, and December 31, 2027. Failure to meet these performance targets could result in a lower percentage of units vesting, impacting executive compensation.
- The range of RSU vesting percentages (75%-115% for 2023-2025 EBITDA, and 50%-150% for 2024-2026 and 2025-2027 EBITDA) introduces variability in future compensation based on financial performance.
Future Outlook
The future vesting of a significant portion of the CEO's Restricted Stock Units is directly tied to Astronics Corp.'s average annual adjusted EBITDA performance over the next several years (2023-2025, 2024-2026, and 2025-2027). The actual number of units vesting will range from 50% to 150% of the target, depending on the company's financial results against these performance metrics.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, specifically the exercise of stock options and subsequent tax-related share withholdings by a senior executive. Such transactions are common across publicly traded companies and reflect standard executive compensation practices. The performance-based vesting of Restricted Stock Units (RSUs) tied to adjusted EBITDA is a typical incentive structure designed to align executive interests with shareholder value creation, a common practice in the aerospace and defense, and test and measurement industries where Astronics operates.
Comparison to Industry Standards
- The use of stock options and performance-based Restricted Stock Units (RSUs) as part of executive compensation is a standard practice across industries, including aerospace and defense, and test and measurement, where Astronics Corp. operates.
- The structure of RSU vesting, tied to financial metrics like adjusted EBITDA over multi-year periods, is consistent with corporate governance best practices aimed at incentivizing long-term performance and aligning executive compensation with shareholder returns, similar to programs seen at peers like TransDigm Group (TDG) or HEICO Corporation (HEI).
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Disclosure of Trading Plan | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 11/20/2025 | Indicates a pre-arranged trading plan, which helps mitigate concerns about insider trading by establishing a schedule for transactions in advance, promoting transparency and compliance with SEC regulations. |
Stakeholder Impact
- Shareholders: Provides transparency regarding executive stock ownership and compensation activities, which can influence investor confidence. The exercise of options at a lower price than the tax withholding price indicates a gain for the executive, which is generally positive for shareholders if it reflects stock appreciation.
- Employees: The performance-based RSU vesting aligns executive incentives with overall company performance, potentially motivating efforts that benefit all employees through a stronger company.
- Management: The transactions directly impact the CEO's personal holdings and compensation, with future RSU vesting tied to the company's financial performance.
Next Steps
- Vesting of 9,206 target Restricted Stock Units on February 23, 2026, contingent on 2023-2025 adjusted EBITDA performance.
- Vesting of 26,450 target Restricted Stock Units on February 23, 2027, contingent on 2024-2026 adjusted EBITDA performance.
- Vesting of 25,250 target Restricted Stock Units on February 27, 2028, contingent on 2025-2027 adjusted EBITDA performance.
- Ongoing monitoring of Astronics Corp.'s adjusted EBITDA performance to determine the actual vesting percentage of the outstanding Restricted Stock Units.
Key Dates
| Date | Description |
|---|---|
| 12/03/2016 | Date exercisable for options with $27.72 exercise price, expiring 12/03/2025. |
| 12/14/2017 | Date exercisable for options with $31.76 exercise price, expiring 12/14/2026. |
| 12/12/2018 | Date exercisable for options with $35.61 exercise price, expiring 12/12/2027. |
| 12/13/2019 | Date exercisable for options with $31.57 exercise price, expiring 12/13/2028. |
| 12/09/2020 | Date exercisable for options with $30.04 exercise price, expiring 12/09/2029. |
| 01/22/2022 | Date exercisable for options with $14.45 exercise price, expiring 01/22/2031. |
| 12/09/2022 | Date exercisable for options with $11.13 exercise price, expiring 12/09/2031. |
| 01/01/2023 | Start of performance period for certain Restricted Stock Units (RSUs) vesting on February 23, 2026. |
| 12/16/2023 | Date exercisable for options with $9.74 exercise price, expiring 12/16/2032. |
| 01/01/2024 | Start of performance period for certain Restricted Stock Units (RSUs) vesting on February 23, 2027. |
| 12/07/2024 | Date exercisable for options with $15.15 exercise price, expiring 12/07/2033. |
| 01/01/2025 | Start of performance period for certain Restricted Stock Units (RSUs) vesting on February 27, 2028. |
| 11/20/2025 | Date of reported transactions (option exercise and tax withholding). |
| 11/24/2025 | Date of inadvertent filing of a Form 4 as an amendment instead of an original. |
| 11/25/2025 | Signature date of the current Form 4 filing. |
| 12/03/2025 | Expiration date for exercised options with $27.72 exercise price. |
| 12/05/2025 | Date exercisable for options with $16.55 exercise price, expiring 12/05/2034. |
| 12/31/2025 | End of performance period for certain Restricted Stock Units (RSUs) vesting on February 23, 2026. |
| 02/23/2026 | Vesting date for 9,206 target Restricted Stock Units, contingent on 2023-2025 adjusted EBITDA. |
| 12/14/2026 | Expiration date for options with $31.76 exercise price. |
| 12/31/2026 | End of performance period for certain Restricted Stock Units (RSUs) vesting on February 23, 2027. |
| 02/23/2027 | Vesting date for 26,450 target Restricted Stock Units, contingent on 2024-2026 adjusted EBITDA. |
| 12/12/2027 | Expiration date for options with $35.61 exercise price. |
| 02/27/2028 | Vesting date for 25,250 target Restricted Stock Units, contingent on 2025-2027 adjusted EBITDA. |
| 12/13/2028 | Expiration date for options with $31.57 exercise price. |
| 12/09/2029 | Expiration date for options with $30.04 exercise price. |
| 01/22/2031 | Expiration date for options with $14.45 exercise price. |
| 12/09/2031 | Expiration date for options with $11.13 exercise price. |
| 12/16/2032 | Expiration date for options with $9.74 exercise price. |
| 12/07/2033 | Expiration date for options with $15.15 exercise price. |
| 12/05/2034 | Expiration date for options with $16.55 exercise price. |
Keywords
Astronics, ATRO, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, CEO, Beneficial Ownership, EBITDA, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.